TrialMedical oncology (Northwood, London, England)2013

Sorafenib in hepatocellular carcinoma: prospective study on adverse events, quality of life, and related feasibility under daily conditions.

Paola Rita Brunocilla et al.PubMed ↗Publisher ↗

No numbers read from the abstract.